AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)

Recruiting Observational Study
Colorectal Cancer Liver Metastases (CRLM)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Observational
Participants needed
1,500 (estimated)
Sponsor
Tongji Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This multicenter, retrospective study aims to develop and validate a multimodal deep learning model for predicting the risk of metachronous liver metastasis in patients with stage I-III colorectal cancer following curative resection. The model will integrate preoperative contrast-enhanced CT imaging, digitized histopathological whole-slide images, and standard clinical-pathological data. The prim…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18-75 years, any gender. * Histologically confirmed primary colon or rectal adenocarcinoma. * Underwent curative radical resection (R0 resection) for colorectal cancer. * Preoperative contrast-enhanced abdominal/pelvic CT scan performed within 1 month before surgery, with …
Contacts

Yang wu, M.D.

13636076910

255001907@qq.com

CONTACT